There are two types of cholinesterases, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), that are attractive as candidate targets for the treatment of Alzheimer’s disease [89,90]. The gene discussed is ACHE; the disease is Alzheimer disease.